A5032978103- Coronary Interventions and Diagnostics
- Peripheral Artery Disease Management
- Cardiac Imaging and Diagnostics
- Cardiac Valve Diseases and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Aortic aneurysm repair treatments
- Cerebrovascular and Carotid Artery Diseases
- Vascular Procedures and Complications
- Renal and Vascular Pathologies
- Skin Diseases and Diabetes
- Cardiac, Anesthesia and Surgical Outcomes
- Congenital Heart Disease Studies
- Venous Thromboembolism Diagnosis and Management
- Cardiac pacing and defibrillation studies
- Cardiac and Coronary Surgery Techniques
- Botulinum Toxin and Related Neurological Disorders
- Advancements in Photolithography Techniques
- Pain Management and Treatment
- Urticaria and Related Conditions
- Endometriosis Research and Treatment
- Diagnosis and Treatment of Venous Diseases
- Uterine Myomas and Treatments
- Blood properties and coagulation
- Private Equity and Venture Capital
Ospedale San Carlo
2019-2022
ASST Fatebenefratelli Sacco
2017-2020
Ospedale Garibaldi
2019-2020
University of Naples Federico II
1998-2018
Fatebenefratelli Hospital
2017-2018
University of Campania "Luigi Vanvitelli"
2017-2018
Ospedale Monaldi
2017-2018
Fondazione Toscana Gabriele Monasterio
2017
Regione Toscana
2017
Federico II University Hospital
2017
Stent underexpansion increases the risk of cardiac adverse events. At present, there are limited options to treat refractory stent underexpansion. In this context, intravascular lithotripsy (IVL) system might be a safe and effective strategy.We aimed evaluate safety efficacy IVL in addressing resistant due heavy underlying calcification.This was an international multicentre registry including patients receiving therapy from December 2017 August 2020. Angiographic intracoronary imaging data...
Aims The purpose of the EASTBOURNE registry is to evaluate immediate and long-term clinical performance a novel sirolimus-coated balloon (SCB) in real-world population patients with coronary artery disease. We here present prespecified interim analysis after enrollment first 642 who obtained 1-year follow-up. Methods prospective, international, multicenter, all-comer investigator-driven registry, which enrolling consecutive treated SCB at 42 European Asiatic centers. Primary study endpoint...
Abstract Objectives To test the long‐term efficacy of a sirolimus‐coated balloon (SCB). Background Nanoluté was prospective registry to evaluate clinical performance novel SCB (Concept Medical Research Private Limited, India) for treatment de novo coronary lesions and in‐stent restenosis (ISR). We here present 24 months data. Methods All patients treated with any type indication between July 2012 September 2015 were enrolled at Indian centers clinically followed up months. Primary endpoints...
Serum concentrations of soluble human leukocyte class I antigens (sHLA-I) and the intercellular adhesion molecule-1 (sICAM-1) are increased in early inflammatory stages several immune-related diseases. These molecules also exert immunomodulatory activity, including regulation natural killer (NK) cell cytotoxicity. The aim this study was to verify whether sHLA-I sICAM-1 serum related various pelvic endometriosis, which is an disorder associated with impaired in-vitro NK activity. were similar...
Drug-coated balloons (DCBs) are a recognized alternative to stents for the treatment of in-stent restenosis (ISR), and there is some initial clinical evidence about their efficacy small coronary vessels. Newer-generation DCBs were developed overcome reduced deliverability previous generation, also warranting more effective drug delivery vessel wall. However, vast majority new-generation still lack reliability due paucity data.Between 2012 2015, all patients treated with Elutax SV DCB (Aachen...
To evaluate the angiographic performance of a novel sirolimus-coated balloon (SCB) in de novo coronary lesions.Out an all-comer prospective registry patients treated with SCB at our center from April 2016 to September 2017, we selected those for stenosis on native vessel, scheduled control least 4 months after index procedure. We performed centralized, blinded core-lab adjudicated quantitative angiography analysis. Primary endpoint was late lumen loss. Secondary endpoints were binary...
Objectives to understand the role of a transradial (TR) secondary approach during complex percutaneous interventions. Background The value TR route for ancillary vascular has not been adequately validated in this setting, and there is scant data on its reducing bleeding complications. Methods In present study we retrospectively included patients undergoing following interventions requiring two approaches at nine high‐volume centers Italy: structural cardiac interventions, PCI, endovascular...
Abstract Aims We evaluated the 1-year clinical events, pharmacological management, and quality of life in a contemporary cohort stable coronary artery disease (CAD) patients managed by cardiologists. Methods results START (STable Coronary Artery Diseases RegisTry) was prospective, observational, nationwide study that enrolled 5070 CAD over 3 months 183 cardiology centres Italy. At 1 year, 4790 (94.5%) had data on vital status. Death occurred 107 (2.2%) cause death cardiovascular 41 (38.3%)...
Abstract Coronary Sinus Reducer (Neovasc, Inc., Richmond B.C., Canada) has shown to be an effective and safe treatment option for the of refractory angina. Until now, a few number complications related its implantation have been reported. sinus perforation is rare complication, more often cardiac surgery procedures. We report first case coronary after implantation.
Abstract Carotid artery stenting (CAS) is a valid and effective alternative to endoatherectomy when performed by experienced operators. The conventional approach used the transfemoral one, but in last 10 years transradial (TR) approach, standard access for cardiac catheterization, became widely adopted peripheral vascular interventions, included extracranial carotids. Preliminary experiences suggest this as safe effective, especially specific anatomical clinical settings that have been shown...
Abstract Background Patients with small vessel disease (SVD) are at higher risk of adverse events after PCI compared to non‐SVD patients. In this subset, the use bioresorbable vascular scaffolds (BVS) has raised particular concern. Objective We aimed compare outcomes Absorb BVS versus a 2nd‐generation metallic everolimus‐eluting stents (EES) in SVD setting, by pooling patients from three large, prospective studies. Methods (reference diameter ≤2.75 mm QCA) and treated were identified Italian...
Abstract Aims Recently, the cardiovascular outcomes for people using anticoagulation strategies (COMPASS) trial demonstrated that dual therapy reduced compared with aspirin alone in patients stable atherosclerotic disease. Methods and results We sought to assess proportion of eligible COMPASS compare epidemiology outcome these those without inclusion or any exclusion criteria a contemporary, nationwide cohort coronary artery Among 4068 detailed information allowing evaluation eligibility,...
With this prospective study we aim at investigating the long-term outcome of a consecutive cohort patients successfully treated with bioresorbable scaffold (BVS) implantation.It is not clearly understood if there relation between technique BVS implantation and outcome.Between December 2012 2014, all were included in registry received an angiographic follow-up. After run-in phase, implanted using specific consisting aggressive predilation, correct sizing, visually determined, high-pressure...